• 1
    Han Z-H, Palnitkar S, Rao DS, Nelson D, Parfitt AM. Effects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res. 1997; 12: 498508.
  • 2
    Parfitt AM. Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry. Curr Opin Nephrol Hypertens. 2003; 12: 387408.
  • 3
    Parfitt AM. The cellular mechanisms of osteoid accumulation in metabolic bone disease. In: Mineral Metabolism Research in Italy, Vol. 4. Milano, Wichtig Editore, 1984: 39.
  • 4
    Meunier PJ, Sellami S, Briancon D, Edouard C. Histological heterogeneity of apparently idiopathic osteoporosis. In: Deluca H et al, eds. Osteoporosis: Recent Advances in Pathogenesis and Treatment. Baltimore: University Park Press, 1981: 293302.
  • 5
    Whyte MP, Bergfeid MA, Murphy WA, Avioli LV, Teitelbaum SL. Postmenopausal osteoporosis: a heterogenous disorder as assessed by histomorphometric analysis of iliac crest bone from untreated patients. Am J Med. 1982; 72: 192201.
  • 6
    Weinstein RS. The histological heterogeneity of osteopenia in the middle-aged and elderly patient. In: Feldman ED, ed. Nutrition in the Middle and Later Years. Boston: PSG Publishing Co. Inc., 1983: 211225.
  • 7
    Recker RR, Barger-Lux J. Bone remodeling findings in osteoporosis. In: Marcus R, Feldman D, Kelsey J. eds. Osteoporosis, 2nd Ed. San Diego, CA: Academic Press, 2001: 5970.
  • 8
    Eriksen EF, Langdahl B, Vesterby A, et al. Hormone replacement therapy prevents osteoclastic hyperactivity: a histomorphometric study in early postmenopausal women. J Bone Miner Res. 1999; 14: 12171221.
  • 9
    Parfitt AM, Mathews CHE, Villanueva AR, Kleerekoper M, Frame B, Rao DS. Relationship between surface, volume and thickness of iliac trabecular bone in aging and in osteoporosis: Implications for the microanatomic and cellular mechanism of bone loss. J Clin Invest. 1983; 72: 13961409.
  • 10
    Cohen-Solal M, Shih M-S, Lundy MW, Parfitt AM. A new method for measuring cancellous bone erosion depth: Application to the cellular mechanisms of bone loss in postmenopausal osteoporosis. J Bone Miner Res. 1991; 6: 13311338.
  • 11
    Parfitt AM, Villanueva AR, Foldes J, Rao DS. Relations between histologic indices of bone formation: implications for the pathogenesis of spinal osteoporosis. J Bone Miner Res. 1995; 10: 466473.
  • 12
    Sedlin ED, Frost HM, Villanueva AR. The Eleventh rib biopsy in the study of metabolic bone disease, Henry Ford Hosp. Med Bull. 1963; 11: 217219.
  • 13
    Villanueva AR, Ilnicki L, Duncan H, Frost HM. Bone and cell dynamics in the osteoporoses: a review of measurements by tetracycline bone labeling. Clin Orthop. 1966; 49: 135150.
  • 14
    Villanueva A, Frost H, Ilnicki L, Frame B, Smith R, Arnstein R. Cortical bone dynamics measured by means of tetracycline labeling in 21 cases of osteoporosis. 1966. J Lab Clin Med. 68: 598616.
  • 15
    Frost HM. Defining osteopenia and osteoporoses: another view (with insights from a new paradigm). Bone. 1997; 20: 385391.
  • 16
    Kanis JA, Melton JL, Christiansen C, Johnston CC, Haltaev N. Perspective: The diagnosis of osteoporosis. J Bone Miner. Res. 1994; 9: 11371142.
  • 17
    Qiu S, Rao DS, Palnitkar S, Parfitt A. Reduced iliac cancellous osteocyte density in patients with osteoporotic vertebral fracture. J Bone Miner Res. 2003; 18: 16571663.
  • 18
    Kleerekoper M, Peterson E, Nelson DA, et al. A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis. Osteoporos Int. 1991; 1: 155161.
  • 19
    Kleerekoper M, Parfitt AM, Ellis BI. Measurement of vertebral fracture rates in osteoporosis. In: Christiansen C, Arnaud CD, Nordin BEC, Parfitt AM, Peck WA, Riggs BL, eds. Osteoporosis Aalborg Stifisbogtrykkeri 1984: 103109.
  • 20
    Parfitt AM, Duncan H. Metabolic bone disease affecting the spine. In: Rothman R, Simeone F, eds. The Spine 2nd ed. Philadelphia, PA, USA: WB Saunders, 1982: 775905.
  • 21
    Kleerekoper M, Nelson DA, Peterson EL, et al. Reference data for bone mass, calciotropic hormones, and biochemical markers of bone remodeling in older (55–75) postmenopausal white and black women. J Bone Miner Res. 1994; 9: 12671276.
  • 22
    Rao DS. Practical approach to bone biopsy. In: Recker RR, ed. Bone Histomorphometry: Techniques and Interpretation. Boca Raton, FL USA: CRC Press, 1983: pp 311.
  • 23
    Parfitt AM, Podenphant J, Villaneueva AR, Frame B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: A bone histomorphometric study. Bone. 1985; 6: 211220.
  • 24
    Parfitt AM, Foldes J, Villanueva AR, Shih MS. The difference in label length between demethylchlortetracycline and oxytetracycline: Implications for the interpretation of bone histomorphometry. Calc Tiss Int. 1991; 48: 7477.
  • 25
    Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry nomenclature, symbols and units. Report of the ASBMR histomorphometry nomenclature committee. J Bone Miner Res. 1987; 2: 595610.
  • 26
    Parfitt AM. Bone-forming cells in clinical conditions. In: Hall BK, ed. Bone: A Treatise, Vol. 1, The Osteoblast and Osteocyte. Caldwell, NJ: Telford Press, 1990: 351429.
  • 27
    Foldes J, Shih M-S, Parfitt AM. Frequency distributions of tetracycline based measurements: Implications for the interpretation of bone formation indices in the absence of double labeled surfaces. J Bone Miner Res. 1990; 5: 10631067.
  • 28
    Villanueva AR, Matthews CHE, Parfitt AM. Relationship between the size and shape of osteoblasts and the width of osteoid seams in bone. In: Takahashi H, ed. Handbook of Bone Morphometry. Nishimara, Nugata, 1983: 191196.
  • 29
    Villanueva AR, Sypitkowski C, Parfitt AM. A new method for identification of cement lines in undecalcified, plastic embedded sections of bone. Stain Technol. 1986; 61: 8388.
  • 30
    Qiu M-C, Mathews C, Parfitt AM. Osteoclastic resorption of osteoid in secondary hyperparathyroidism. In: Frame B, Potts JT Jr, eds. Clinical Disorders of Bone and Mineral Metabolism. Amsterdam: Excerpta Medica, 1983: 209212.
  • 31
    Kimmel DB, Recker RR, Gallagher JC, Vaswani AS, Aloia JF. A comparison of iliac bone histomorphometric data in post-menopausal osteoporotic and normal subjects. Bone Miner. 1990; 11: 217235.
  • 32
    Parfitt AM. Surface specific bone remodeling in health and disease. In: Kleerekoper M, Krane S, eds. Clinical Disorders of Bone and Mineral Metabolism. New York: Mary Ann Liebert Publishers, Inc, 1989: 714.
  • 33
    Qiu S, Rao DS, Palnitkar S, Parfitt AM. Independent contributions of cancellous and cortical bone deficits to vertebral fracture risk in postmenopausal women. J Bone Min Res. 2006; 21: 17911796.
  • 34
    Parfitt AM, Simon LS, Villanueva AR, Krane SM. Procollagen type I carboxyterminal extension peptide in serum as a marker of collagen biosynthesis in bone. Correlation with iliac bone formation rates and comparison with total alkaline phosphatase. J Bone Miner Res. 1987; 2: 427436.
  • 35
    Eastell R, Delmas PD, Hodgson SF, Eriksen EF, Mann KG, Riggs BL. Bone formation fate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab. 1988; 67: 741748.
  • 36
    Altman DG. Practical Statistics for Medical Research. London. UK: Chapman and Hall, 1991.
  • 37
    Sokal RR, Rohlf FJ. Biometry: The Principles and Practices of Statistics in Biological Research 2nd ed. San Francisco CA USA: W.H. Freeman, 1981.
  • 38
    Qui S, Palnitkar S, Rao DS, Parfitt AM. Relationship between osteocyte density and bone formation rate in human cancellous bone. Bone. 2002; 31: 709711.
  • 39
    Foldes J, Parfitt AM, Shih M-S, Rao DS, Kleerekoper M. Structural and geometric changes in iliac bone: Relationship to normal aging and osteoporosis. J Bone Miner Res. 1991; 6: 759766.
  • 40
    Parfitt AM, Han Z-H, Palnitkar S, Rao DS, Shih M-S, Nelson D. Effects of ethnicity and age or menopause on osteoblast function, bone mineralization and osteoid accumulation in iliac bone. J Bone Min Res. 1997; 12: 18641872.
  • 41
    Arlot ME, Delmas PD, Chappard D, Meunier PJ. Trabecular and endocortical bone remodeling in postmenopausal osteoporosis: comparison with normal postmenopausal women. Osteoporosis Int. 1990; 1: 4149.
  • 42
    Weinstein RS, Parfitt AM, Marcus R, Greenwald M, Crans G, Muchmore DB. Effects of raloxifene, hormone replacement therapy, and placebo on bone turnover in postmenopausal women. Osteoporos Int. 2003; 14: 814822.
  • 43
    Donovan MA, Dempster D, Zhou H, McMahon DJ, Fleischer J, Shane E. Low bone formation in premenopausal women with idiopathic osteoporosis. J Clin Endocrinol Metab. 2005; 90: 33313396.
  • 44
    Rauch F, Travers R, Norman ME, Taylor A, Parfitt AM, Glorieux FH. The bone formation defect in idiopathic juvenile osteoporosis is surface-specific. Bone. 2002; 31: 8589.
  • 45
    Ott SM. Bone formation periods studied with triple tetracycline labels in women with postmenopausal osteoporosis. J. Bone Miner Res. 1993; 8: 443450.
  • 46
    Hattner RS, Ilnicki IP, Hodge HC. The dose-response relationship of tetracycle to the detectability of labeled osteons by fluorescence microscopy. In: Norman AW, Schaefer K, Coburn JW, DeLuca HF, Fraser D, Grifoleit HG, Herrath DV, eds. Vitamin D, Biochemical, Chemical and Clinical Aspects Related to Calcium Metabolism. New York, NY, U.S.A.: DeGruyter, pp 377380.
  • 47
    Jones SJ. Secretory territories and rate of matrix production of osteoblasts. Calcif Tissue Res. 1974; 14: 309315.
  • 48
    Eriksen EF. Normal and pathological remodeling of human trabecular bone three dimensional reconstruction of the remodeling sequence, in normals and in metabolic bone disease. Endocr Rev. 1986; 7: 379408.
  • 49
    Marie PJ. Cellular and molecular alterations of osteoblasts in human disorders of bone formation. Histol Histopathol. 1999; 14: 525538.
  • 50
    Brown MEA, Arlot ME, Reeve J. Osteoblast density and the evolution of BMUs in vertebral osteoporosis. Bone. 1993; 14: 473479.
  • 51
    Jilka RL, Weinstein RS, Parfitt AM, Manolagas SC. Quantifying osteoblast apoptosis: challenges and rewards. J Bone Min Res. 2007; 22: 14921501.
  • 52
    Eriksen EF, Hodgson SF, Eastell R, Cedel SL, O'Fallon WM, Riggs BL. Cancellous bone remodeling in type I (postmenopausal) osteoporosis: quantitative assessment of rates of formation, resorption and bone loss at tissue and cellular levels. J Bone Min Res. 1990; 5: 311319.
  • 53
    Flora L, Hassing GS, Parfitt AM, Villanueva AR. Comparative skeletal effects of two diphosphonates in dogs. In: Jee WSS, Parfitt AM, eds. Bone Histomorphometry: Third International Workshop. Paris, Armour-Montagu, 1981: 389407.
  • 54
    Parfitt AM. Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. Osteoporosis 3rd Edition Marcus R, Feldman D, Nelson D, Rosen C, eds. San Diego: Elsevier, 2007.
  • 55
    Parfitt AM, Kleerekoper M, Villanueva AR. Increased bone age: Mechanisms and consequences.: In: Christiansen C, Johansen C, Riis BJ, eds. Osteoporosis. Copenhagen: Osteopress ApS, 1987: pp. 301308.
  • 56
    Ciarelli TE, Fyhrie DP, Parfitt AM. Effects of vertebral bone fragility and bone formation rate on the mineralization levels of cancellous bone from white females. Bone. 2003; 32: 311315.
  • 57
    Weinstein RS. Perspective: true strength. J Bone Min Res. 2000; 15: 621625.
  • 58
    Heaney R. Is the paradigm shifting? Bone. 2003; 33: 457465.
  • 59
    Parfitt AM. Cortical porosity in postmenopausal and adolescent wrist fractures. In: Uhthoff H, Jaworski ZFG, eds. Current Concepts of Bone Fragility. Springer-Verlag: Berlin Heidelberg, 1986. 167172.
  • 60
    Bell KL, Loveridge N, Reeve J, Thomas CD, Feik SA, Clement JG. Super-osteons (remodeling clusters) in the cortex of the femoral shaft: influence of age and gender. Anat Rec. 2001; 264: 378386.
  • 61
    Kotowicz MA, Klee GG, Kao PC, et al. Relationship between serum intact parathyroid hormone concentrations and bone remodeling in type i osteoporosis: evidence that skeletal sensitivity is increased. Osteoporosis Int. 1990; 1: 1422.
  • 62
    Manolagas SC. The role of IL-6 type cytokines and their receptors in bone. Ann NY Acad Sci. 1998; 840: 194204.
  • 63
    Lean JM, Davies JT, Fuller K, et al. A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest. 2003; 112: 915923.
  • 64
    Almeida M, Han L, Martin-Millan M, et al. Skeletal involution by age-associated oxidative stress and its acceleration by loss of sex steroids. J Biol Chem. 2007; 282: 2728527297.
  • 65
    Mullender MG, Tan SD, Vico L, Alexandre C, Klein-Nulend J. Differences in osteocyte density and bone histomorphometry between men and women and between healthy and osteoporotic subjects. Calt Tiss Int. 2005; 291296.
  • 66
    Eriksen EF, Melsen F, Moseklide L. Reconstruction of the resorptive site in iliac trabecular bone – kinetic model for bone resorption in 20 normal individuals. Metab Bone Dis Rel Res. 1984; 5: 235242.